LogoLogo
  • About Us
    • About Aurobindo
    • Vision / Mission
    • Milestones
    • R&D
    • Manufacturing
    • Management
      • Board of Directors
    • Our Presence
  • Our Business
    • APUSA
    • Europe
    • Growth Markets
    • ARV
      • Overview
      • Key facts about HIV/AIDS
      • Products
      • Global Partners
      • Gallery
      • Corporate Video
    • Apitoria (API)
    • Eugia (Speciality products)
    • Curateq (Biosimilars) / Peptide
  • Sustainability
    • ESG / Sustainability
      • ESG Profile
      • Sustainability Reports
      • BMW Reports
    • Social Accountability Standards
      • Social Compliance Certification
      • Sustainability of Social Accountability Standards
      • Human Rights Policy
      • Progressive Health and Safety Practices
      • Community Impact
      • Supply Chain Management
      • Supplier Code of Conduct
    • CSR
      • Aurobindo Pharma Foundation
      • CSR Policy
      • Annual Report
      • Gallery
      • Annual Action Plan
      • Impact Assessment Reports - CSR Projects
    • Access to Healthcare
      • PEPFAR program
  • Investors
    • Results, Reports & Presentations
      • Results Announcements
      • Annual Reports
      • Financials - Subsidiaries
      • Related Party Transactions
    • Shareholder Information
      • Shareholding Pattern
      • Buyback of shares
      • Share Performance
      • Financial Highlights
      • Notice of Board Meetings
      • General Meetings
      • Dividend Record
      • Scheme of Arrangements
      • Unpaid Dividend Account Details
      • Registrar and Share Transfer Agent
      • Contact Details for Investor Grievance Redressal
    • Corporate Governance
      • Board of Directors
      • Governance Policies
      • Code of Conduct
      • Code of Practices and Procedures for Fair Disclosure
      • Appointment and Resignation of Directors
      • Contact Details of KMPs
      • IR Contacts
    • Disclosures Under Regulation 46
      • Disclosures under Regulation 46 of the LODR
  • Media
    • Press Releases
    • Corporate Kit
  • Careers
    • Our Culture & Values
    • Life @ Aurobindo
    • Work with us / Oppurtunities
  • Contact Us

Investors

Commitment towards creating consistent value for our shareholders

Unpaid and Unclaimed Dividend as on

31.03.2024
31.03.2023
31.03.2022
Archives

FY2022-23 TO FY2023-24

Icon

FY2021-22

Icon

FY2020-21

Icon

FY2018-19 TO FY2019-20

Icon

FY2016-17 TO FY2017-18-2

Icon

FY2016-17 TO FY2017-18-1

Icon

Unclaimed Second Interim Dividend 2023-24

Icon

Unclaimed Interim Dividend 2023-24

Icon

IEPF Unpaid Query

Shares and Dividends transferred to IEPF

Icon

Shares and Dividend to be transferred to IEPF

Icon

Newspapers - IEPF

2024
2023
2022
2021
2020
2019
2018
2017

IEPF Notice Published in November 2024

Icon

IEPF Notice published in September 2024

Icon

IEPF Notice published in March 2024

Icon

Nodal Officer for IEPF Query

Nodal Officer IEPF for Website

Icon

Weblink for IEPF Refund - Procedure

Weblink for IEPF - Refund Procedure

Icon
Footer Logo

REGISTERED OFFICE

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038, Telangana, India.

CORPORATE OFFICE

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City,
Raidurg Panmaktha, Rangareddy District,
Hyderabad - 500032, Telangana, India.

  • About Us
  • Our Business
  • Sustainability
  • Investors
  • Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map

© Copyright 2025 Aurobindo Pharma Limited. All rights reserved.